Literature DB >> 10712630

NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis.

J de Vente1, M Markerink-van Ittersum, J van Abeelen, P C Emson, H Axer, H W Steinbusch.   

Abstract

Nitric oxide synthase (NOS) activity and NO-mediated cGMP synthesis were studied in the rat forebrain of control animals and animals which had received a unilateral lesioning of dopaminergic or serotonergic pathways. Lesioning of the dopaminergic innervation using 6-hydroxydopamine resulted in a 50% decrease in NOS activity in the lesioned frontal cortex and caudate putamen. Lesioning of the serotonergic innervation using 5,7-dihydroxytryptamine had no effect on NOS activity. NO-mediated cGMP accumulation in rat forebrain slices was not affected by 6-hydroxydopamine or 5,7, -dihydroxytryptamine lesioning. Using cGMP immunocytochemistry, it was demonstrated that NO-mediated cGMP synthesis was absent from dopaminergic, serotonergic, GABA-ergic and neuronal NOS-containing nerve fibres. A minor colocalization of cGMP immunoreactivity was found in parvalbumin-containing fibres in the cortex. Extensive colocalization between cGMP immunoreactivity and the acetylcholine transporter was found in all cortical areas and in the caudate putamen. There was no effect of the lesions on this colocalization. These results demonstrate NO-mediated cGMP accumulation in cholinergic fibres in the forebrain of the rat and suggest an anterograde signalling function of NO in cholinergic neuronal systems in the cortex and caudate putamen of the rat.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712630     DOI: 10.1046/j.1460-9568.2000.00927.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  12 in total

1.  NO nerves and their targets in a tapeworm: An immunocytochemical study of cGMP in Hymenolepis diminuta.

Authors:  Margaretha K S Gustafsson; Nadezhda B Terenina; Maria Reuter; Sergei O Movsessian
Journal:  Parasitol Res       Date:  2003-02-19       Impact factor: 2.289

2.  Inhibition of dopamine signaling suppresses cGMP accumulation in rd1 retinal organ cultures.

Authors:  Ju Zhang; Angela M Richmond; Judith M Ogilvie
Journal:  Neuroreport       Date:  2014-05-28       Impact factor: 1.837

3.  Effects of local infusions of apomorphine on the extracellular citrulline level in the striatum: Involvement of D1 and D2 dopamine receptors.

Authors:  S A Savel'ev
Journal:  Neurosci Behav Physiol       Date:  2006-11

4.  Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission.

Authors:  Sara Arcangeli; Alessandro Tozzi; Michela Tantucci; Cristiano Spaccatini; Antonio de Iure; Cinzia Costa; Massimiliano Di Filippo; Barbara Picconi; Carmen Giampà; Francesca Romana Fusco; Salvatore Amoroso; Paolo Calabresi
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

5.  Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition.

Authors:  Sarah Threlfell; Anthony R West
Journal:  Basal Ganglia       Date:  2013-12-01

6.  On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system.

Authors:  Seyed Soheil Saeedi Saravi; Roya Amirkhanloo; Alireza Arefidoust; Rahele Yaftian; Seyed Sobhan Saeedi Saravi; Mohammad Shokrzadeh; Ahmad Reza Dehpour
Journal:  Metab Brain Dis       Date:  2015-11-19       Impact factor: 3.584

7.  Investigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic Systems.

Authors:  M Mitkovski; F E Padovan-Neto; R Raisman-Vozari; L Ginestet; C A da-Silva; E A Del-Bel
Journal:  Front Physiol       Date:  2012-09-25       Impact factor: 4.566

8.  Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease?

Authors:  Anthony R West; Kuei Y Tseng
Journal:  Front Syst Neurosci       Date:  2011-06-30

9.  Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.

Authors:  Fernando Eduardo Padovan-Neto; Marcela Bermúdez Echeverry; Silvana Chiavegatto; Elaine Del-Bel
Journal:  Front Syst Neurosci       Date:  2011-06-10

10.  Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation.

Authors:  D Centonze; A Pisani; P Bonsi; P Giacomini; G Bernardi; P Calabresi
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.